首页|期刊导航|亚太传统医药|不同中医证型2型糖尿病合并非酒精性脂肪性肝病患者空腹C肽与FIB-4指数的相关性研究

不同中医证型2型糖尿病合并非酒精性脂肪性肝病患者空腹C肽与FIB-4指数的相关性研究OA

Study on the Relationship Between Fasting C-Peptide and FIB-4 Index in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease of Various TCM Syndrome Types

中文摘要英文摘要

目的:探讨不同中医证型2型糖尿病(T2DM)合并非酒精性脂肪性肝病(NAFLD)患者的空腹C肽与FIB-4指数的相关性,为中医辨证分型及中西医结合治疗提供客观依据.方法:收集150例T2DM合并NAFLD患者,根据中医辨证分为痰瘀互结证、肝郁脾虚证、湿热内蕴证、肝肾亏虚证.记录各组年龄、病程、BMI、糖化血红蛋白(HbA1c)、空腹C肽及FIB-4指数等指标,采用方差分析、非参数检验及Pearson相关性分析进行统计学处理.结果:(1)不同中医证型T2DM合并NAFLD患者的HbA1c比较,差异无统计学意义(P>0.05);肝肾亏虚证组年龄显著高于痰瘀互结证组(P<0.05),病程最长(P<0.05);BMI呈现肝肾亏虚证组<肝郁脾虚证组<痰瘀互结证组<湿热内蕴证组的梯度差异(P<0.05).(2)空腹C肽水平组间差异显著(P<0.05),依次为:肝肾亏虚证组<肝郁脾虚证组<湿热内蕴证组<痰瘀互结证组.(3)FIB-4指数方面,不同中医证型的T2DM合并非NAFLD患者在FIB-4指数上存在显著差异(P<0.05),肝肾亏虚证组FIB-4指数显著高于其他证型(P<0.05),湿热内蕴证组最低.(4)经Pearson相关分析,T2DM合并NAFLD患者空腹C肽水平与FIB-4指数均呈显著正相关(P<0.05).结论:中医证型动态反映NAFLD病理特征与纤维化进程:痰瘀互结证患者IR及空腹C肽水平最高,需化痰祛瘀联合胰岛素增敏剂;肝肾亏虚证FIB-4指数最高,提示纤维化晚期,需滋补肝肾联合抗纤维化治疗;湿热内蕴证FIB-4指数最低,多属脂肪变性早期,宜清热利湿联合代谢调控;空腹C肽与FIB-4指数可为中医辨证提供客观依据,指导分层干预.

Objective:This study investigates the relationship between fasting C-peptide and FIB-4 index in T2DM pa-tients with NAFLD,classified by traditional Chinese medicine(TCM)syndromes,aiming to provide objective evidence for syndrome differentiation and integrative treatment strategies.Methods:A retrospective cohort study included 150 T2DM patients with NAFLD,classified into four TCM syndromes:phlegm-blood stagnation,liver-spleen deficiency,damp-heat retention,and liver-kidney deficiency.The indicators such as age,disease duration,BMI,glycated hemoglobin(HbA1c),fasting C-peptide and FIB-4 index of each group were recorded.Statistical processing was performed using analysis of variance,non-parametric tests and Pearson correlation analysis.Results:(1)There was no statistically sig-nificant difference in HbA1c among patients with T2DM combined with NAFLD of different TCM syndrome types(P>0.05).Patients in the liver-kidney deficiency group were significantly older compared to those in the phlegm-blood stasis group(P<0.05),and they also had the longest disease duration(P<0.05).BMI levels demonstrated a signifi-cant gradient:lowest in the liver-kidney deficiency group,followed by the liver-spleen deficiency group,then the phlegm-blood stasis group,and highest in the damp-heat retention group(P<0.05).(2)Fasting C-peptide levels var-ied significantly across the groups(P<0.05),with the lowest values observed in the liver-kidney deficiency group,fol-lowed by the liver-spleen deficiency group,the damp-heat retention group,and the highest levels found in the phlegm-blood stasis group.(3)Regarding the FIB-4 index,there were significant differences in the FIB-4 index among patients with T2DM combined with non-NAFLD of different TCM syndrome types(P<0.05).FIB-4 index levels were signifi-cantly elevated in the liver-kidney deficiency group compared to other TCM syndrome groups(P<0.05),whereas the lowest levels were observed in the damp-heat retention group,suggesting a potential correlation between syndrome dif-ferentiation and fibrosis severity.(4)Pearson correlation analysis showed that the fasting C-peptide level and FIB-4 in-dex in patients with T2DM combined with NAFLD were significantly positively correlated(P<0.05).Conclusion:The dynamic reflection of TCM syndrome types reflects the pathological characteristics and fibrosis process of NAFLD:Patients with phlegm and blood stasis interstitial syndrome have the highest levels of IR and fasting C-peptide,and require expectorant and blood stasis removal combined with insulin sensitizers.The FIB-4 index is the highest in the syndrome of liver and kidney deficiency,indicating advanced fibrosis.Combined anti-fibrotic treatment with nourishing the liver and kidneys is required.The FIB-4 index is the lowest in the syndrome of internal accumula-tion of damp-heat,which mostly belongs to the early stage of steatosis.Combined metabolic regulation of clearing heat and promoting diuresis is advisable.Fasting C-peptide and FIB-4 index can provide an objective basis for syndrome dif-ferentiation in TCM and guide stratified intervention.

叶枝繁;郑曙琴

辽宁中医药大学 第一临床学院,辽宁 沈阳 110847辽宁中医药大学附属医院 内分泌科,辽宁 沈阳 110032

医药卫生

2型糖尿病非酒精性脂肪肝病中医证型空腹C肽FIB-4指数

Type 2 Diabetes MellitusNonalcoholic Fatty Liver DiseaseTraditional Chinese Medicine Syndrome TypeFasting C-peptideFIB-4 Index

《亚太传统医药》 2026 (2)

72-76,5

全国名老中医专家传承工作室建设项目(国中医药人教函[2022]75号)

10.11954/ytctyy.202602013

评论